Literature DB >> 21087338

Hormonal contraception and HIV-1 transmission.

Catherine A Blish1, Jared M Baeten.   

Abstract

Safe and effective contraceptive choices are essential for women with HIV-1 infection and at risk for HIV-1 infection. Epidemiological and laboratory-based studies suggest that hormonal contraception may influence HIV-1 transmission. Several large studies in high-risk populations indicate that hormonal contraceptive use may modestly increase the risk of HIV-1 acquisition. In addition, HIV-1-infected users of hormonal contraceptives may be more infectious to their uninfected partners, although no studies have directly measured HIV-1 transmission risk from women to men. However, several studies failed to demonstrate a link between contraceptive use and HIV-1 acquisition or transmission, and interpretation of many studies limited by methodological considerations, such as infrequent measurements of contraceptive exposure and HIV-1 status. As a result, many questions remain, and high-quality studies remain needed. It is clear that hormonal contraceptives are not protective against HIV-1 infection and that dual protection with condoms should be the goal for women using hormonal contraception.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087338      PMCID: PMC3058314          DOI: 10.1111/j.1600-0897.2010.00930.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  44 in total

1.  Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4(+) T cells in the cervical epithelium of healthy women.

Authors:  Manyu Prakash; Moses S Kapembwa; Frances Gotch; Steven Patterson
Journal:  J Reprod Immunol       Date:  2002-03       Impact factor: 4.054

2.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

3.  The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy.

Authors:  C K Mauck; M M Callahan; J Baker; K Arbogast; R Veazey; R Stock; Z Pan; C S Morrison; M Chen-Mok; D F Archer; H L Gabelnick
Journal:  Contraception       Date:  1999-07       Impact factor: 3.375

4.  Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.

Authors:  R S Mcclelland; C C Wang; K Mandaliya; J Overbaugh; M T Reiner; D D Panteleeff; L Lavreys; J Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

5.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

Authors:  J M Baeten; P M Nyange; B A Richardson; L Lavreys; B Chohan; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

6.  Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B.

Authors:  Ying C Q Zang; Jyotsnabaran B Halder; Jian Hong; Victor M Rivera; Jingwu Z Zhang
Journal:  J Neuroimmunol       Date:  2002-03       Impact factor: 3.478

7.  Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium.

Authors:  L Miller; D L Patton; A Meier; S S Thwin; T M Hooton; D A Eschenbach
Journal:  Obstet Gynecol       Date:  2000-09       Impact factor: 7.661

8.  Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.

Authors:  Amy E Gillgrass; Ali A Ashkar; Kenneth L Rosenthal; Charu Kaushic
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study.

Authors:  D Avonts; M Sercu; P Heyerick; I Vandermeeren; A Meheus; P Piot
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

Review 10.  Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission.

Authors:  Jared M Baeten; Julie Overbaugh
Journal:  Curr HIV Res       Date:  2003-01       Impact factor: 1.581

View more
  29 in total

Review 1.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

2.  Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4+ T cells to HIV infection.

Authors:  Carley Tasker; Amy Davidow; Natalie E Roche; Theresa L Chang
Journal:  Immunohorizons       Date:  2017-11-01

3.  Genital Inflammation Predicts HIV-1 Shedding Independent of Plasma Viral Load and Systemic Inflammation.

Authors:  Catherine A Blish; R Scott McClelland; Barbra A Richardson; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-01       Impact factor: 3.731

4.  Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.

Authors:  Annelie Tjernlund; Ann M Carias; Sonia Andersson; Susanna Gustafsson-Sanchez; Maria Röhl; Pernilla Petersson; Andrea Introini; Thomas J Hope; Kristina Broliden
Journal:  Biol Reprod       Date:  2015-01-14       Impact factor: 4.285

5.  Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.

Authors:  Brandon L Guthrie; Andrea Introini; Alison C Roxby; Robert Y Choi; Rose Bosire; Barbara Lohman-Payne; Taha Hirbod; Carey Farquhar; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

6.  Medroxyprogesterone acetate impairs human dendritic cell activation and function.

Authors:  N E Quispe Calla; M G Ghonime; T L Cherpes; R D Vicetti Miguel
Journal:  Hum Reprod       Date:  2015-03-03       Impact factor: 6.918

7.  Should DBS for Psychiatric Disorders be Considered a Form of Psychosurgery? Ethical and Legal Considerations.

Authors:  Devan Stahl; Laura Cabrera; Tyler Gibb
Journal:  Sci Eng Ethics       Date:  2017-06-26       Impact factor: 3.525

Review 8.  The reproductive health behaviors of HIV-infected young women in the United States: A literature review.

Authors:  Marion W Carter; Joan M Kraft; Kendra Hatfield-Timajchy; Margaret C Snead; Larisa Ozeryansky; Amy M Fasula; Linda J Koenig; Athena P Kourtis
Journal:  AIDS Patient Care STDS       Date:  2013-12       Impact factor: 5.078

Review 9.  Contraception for HIV-Infected Adolescents.

Authors:  Athena P Kourtis; Ayesha Mirza
Journal:  Pediatrics       Date:  2016-09       Impact factor: 7.124

Review 10.  HIV transmission biology: translation for HIV prevention.

Authors:  Keshet Ronen; Amit Sharma; Julie Overbaugh
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.